FNDC5 and metabolic syndrome: The concentration of irisin after 20 WBC treatments was comparable to baseline (post-hoc, p > 0.05), the differences totalling 0.04 (95% CI −0.8; 0.17) and 0.07 (95% CI −0.03; 0.16) in the MetS and health-women groups, respectively.